Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ophthalmology
•
Uveitis and Ocular Immunology
How do you manage checkpoint inhibitor-associated Vogt-Koyanagi-Harada (VKH) disease in patients who have poorly controlled diabetes?
Related Questions
How do you approach the management of recurrent episcleritis in a patient with RA that is otherwise well-controlled?
How do you approach a patient who has anterior uveitis and is referred for evaluation of ocular TB with a positive Quantiferon gold (as part of their workup) in countries with low TB incidence?
How would you approach management of nodular scleritis in the setting of suspected GCA?
How do you treat idiopathic acute anterior uveitis that recurs immediately after a course of topical corticosteroids?
Do you routinely recommend IV systemic antibiotic therapy in additional to intravitreal antibiotic therapy for exogenous bacterial endophthalmitis?
Is it safe to continue azathioprine in a patient with severe bilateral panuveitis (thought to be related to sarcoidosis) and benign ethnic neutropenia, given worsening neutropenia since starting the medication, or should an alternative immunosuppressive agent be considered?
How do you manage cystoid macular edema (CME) in patients with steroid-induced intraocular hypertension that is resistant to topical treatments?
How do you manage macular-threatening toxoplasma chorioretinitis in pregnancy?
In a patient with isolated HLA B27+ anterior uveitis, how long would you continue immunosuppressive therapy?
When would you consider using selective laser trabeculoplasty (SLT) for managing uveitic glaucoma?
